News
MGRX
0.1337
-8.74%
-0.0128
Weekly Report: what happened at MGRX last week (1109-1113)?
Weekly Report · 4d ago
Mangoceuticals Establishes Series D Preferred Stock Designation
TipRanks · 6d ago
Mangoceuticals to offer up to $10M of tokenized Series D preferred stock
TipRanks · 11/12 14:16
Weekly Report: what happened at MGRX last week (1102-1106)?
Weekly Report · 11/09 09:22
Mangoceuticals, Inc. Announces Proposed Series D Preferred Stock Terms and Combined 2025 and 2026 Annual Meeting Date
NASDAQ · 11/07 03:09
Mangoceuticals Sets Combined 2025 and 2026 Shareholder Meeting
TipRanks · 11/06 22:50
Weekly Report: what happened at MGRX last week (1026-1030)?
Weekly Report · 11/02 09:22
Weekly Report: what happened at MGRX last week (1019-1023)?
Weekly Report · 10/26 09:22
Weekly Report: what happened at MGRX last week (1012-1016)?
Weekly Report · 10/19 09:22
Weekly Report: what happened at MGRX last week (1005-1009)?
Weekly Report · 10/12 09:23
Mangoceuticals completes premium registered direct equity financing
TipRanks · 10/09 20:35
Mangoceuticals Closes Registered Direct Offering Following $2.5M Strategic Investment Commitment In MangoRx IP Holdings To Support Intellectual Property Commercialization
Benzinga · 10/09 20:03
Weekly Report: what happened at MGRX last week (0928-1002)?
Weekly Report · 10/05 09:23
Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
Benzinga · 10/02 12:02
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
Benzinga · 10/02 08:16
Mangoceuticals Secures $2.5 Mln Investment To Advance Antiviral IP Commercialization
NASDAQ · 10/02 06:40
Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why
Benzinga · 10/02 05:22
Mangoceuticals Secures Strategic Investment in MangoRx IP Subsidiary
TipRanks · 10/01 20:18
Mangoceuticals reports $2.5M strategic investment in MangoRx IP Holdings
TipRanks · 10/01 19:55
Mangoceuticals’ MangoRx IP Secures $2.5M Investment From Strategic Investors, Receives Initial $1.75M Tranche
Benzinga · 10/01 19:52
More
Webull provides a variety of real-time MGRX stock news. You can receive the latest news about Mangoceuticals, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About MGRX
Mangoceuticals, Inc. is focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx and is also focused on wellness solutions. It is advancing its proprietary antiviral compound MGX-0024. The Company offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. It has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.